Closing in on its IPO for its animal health unit Zoetis, Pfizer ($PFE) on Thursday reported that it would price shares between $22 and $25 each, potentially raising $2.2 billion when it happens at the end of the month, Bloomberg reports. The company intends to offer 86.1 million shares, a 20% stake, to investors. Article